News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Boston Scientific Corporation (BSX) Stents Lag, CFO Resigns



10/25/2013 6:58:57 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Boston Scientific Corp, which is in the midst of an attempted turnaround, reported weak sales of its heart stents and provided a disappointing fourth-quarter company sales forecast, sending its shares almost 7 percent lower on Thursday. The medical device maker also caused market jitters by announcing that Jeffrey Capello, its chief financial officer since early 2010, would resign effective Dec. 31. He will be replaced by Daniel Brennan, the company's corporate controller.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at Star Tribune


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES